# Paroxysmal Nocturnal Hemoglobinuria (PNH) Registry

> **NCT01374360** · — · COMPLETED · sponsor: **Alexion Pharmaceuticals, Inc.** · enrollment: 6061 (actual)

## Conditions studied

- Paroxysmal Nocturnal Hemoglobinuria

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01374360
- **Lead sponsor:** Alexion Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2004-10-29
- **Primary completion:** 2025-04-14
- **Final completion:** 2025-04-14
- **Target enrollment:** 6061 (ACTUAL)
- **Last updated:** 2026-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01374360

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01374360, "Paroxysmal Nocturnal Hemoglobinuria (PNH) Registry". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT01374360. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*